Impact on immunophenotype of switching from conventional glucocorticoids to modified-release hydrocortisone in congenital adrenal hyperplasia | Synapse
May 6, 2024
Impact on immunophenotype of switching from conventional glucocorticoids to modified-release hydrocortisone in congenital adrenal hyperplasia
Key Points
Key points are not available for this paper at this time.
Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)